Why is Emmessar Biotech falling/rising?

As of 22-Sep, Emmessar Biotech & Nutrition Ltd is experiencing a decline in its stock price, currently at Rs 35.75, which reflects a decrease of Rs 1.33 or 3.59%. The stock has been underperforming, having fallen consecutively for the last two days with a total drop of 9.26%. Today, it opened with a significant loss of 5.31% and reached an intraday low of Rs 35.11. Additionally, the stock's delivery volume has decreased by 47.91% compared to the five-day average, indicating falling investor participation. Despite trading above its moving averages, the overall negative sentiment is evident in its recent performance, with a year-to-date return of -22.79%.
In the broader market context, Emmessar Biotech's short-term performance over the past week shows a remarkable gain of 32.41%, significantly outperforming the Sensex, which only increased by 0.46%. However, this positive short-term trend contrasts sharply with its year-to-date performance and the recent declines, suggesting volatility and potential investor concerns. The stock's liquidity remains adequate for trading, but the recent drop in delivery volume may signal a lack of confidence among investors, contributing to the stock's current downward trajectory.